Company Profile: 23andMe
Summary
23andMe is a personal genomics and biotechnology company that leverages machine learning technology to provide DNA analysis services. It also offers web-based interactive tools to individuals, helping them understand their own genetics information.
Scope
The report provides information and insights into 23andMe, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and business model
- Information on partnerships, funding and awards it received
- Biography of top management.
Reasons to buy
- Gain insights into 23andMes business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its technology focus and success factors.
Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix
2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850
View Report2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850
View Report2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850
View Report2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850
View ReportFill The Form For Sample Request